United Therapeutics buy Wells Fargo & Company
Start price
20.08.24
/
50%
€314.10
Target price
20.08.25
€341.89
Performance (%)
1.56%
Price
02.10.24
€319.00
Summary
This prediction is currently active. With a performance of 1.56%, the BUY prediction by Wells_Fargo___Compan for United Therapeutics is trending in the right direction. This prediction currently runs until 20.08.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
United Therapeutics | -1.269% | -1.269% |
iShares Core DAX® | 1.308% | 1.167% |
iShares Nasdaq 100 | -0.156% | 1.246% |
iShares Nikkei 225® | 1.270% | 0.293% |
iShares S&P 500 | 0.476% | 1.292% |
Comments by Wells_Fargo___Compan for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Wells Fargo & Company from $350.00 to $380.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€255.70
12.06.24
12.06.24
€323.16
12.06.25
12.06.25
24.76%
02.10.24
02.10.24
United Therapeutics
Start price
Target price
Perf. (%)
€220.00
07.03.24
07.03.24
€298.84
07.03.25
07.03.25
45.00%
02.10.24
02.10.24
United Therapeutics
Start price
Target price
Perf. (%)
€224.60
08.12.23
08.12.23
€287.40
08.12.24
08.12.24
43.50%
02.10.24
02.10.24